This Plano Biotech Firm Raised $30 Million to Advance Duchenne Cardiomyopathy Treatment

Plano biotech firm Secretome Therapeutics developing treatments for Duchenne muscular dystrophy and rare cardiomyopathies has secured major funding to advance its research and development. The company closed its $30 million Series A led by RA Capital Management this past month. The funding will support the advancement of STM-01, Secretome’s lead therapeutic candidate for Duchenne-associated cardiomyopathy. … Continued The post This Plano Biotech Firm Raised $30 Million to Advance Duchenne Cardiomyopathy Treatment appeared first on D Magazine.
This article was originally published by D Magazine. Read the full story at the source below.
From Our Partners
Best BBQ in Dallas Guide
Discover the top smokehouses in DFW, from Lockhart to Slowbone
DFW Event Tickets
Exclusive deals on concerts, sports & arts across North Texas
Local Hotel Deals
Save up to 30% on stays in Downtown Dallas & Fort Worth
DFW Brewery Pass
Visit 20+ craft breweries across Dallas and Fort Worth
Sponsored links — we may earn a commission at no cost to you